Hematology

Recent research has revealed that the red blood cell distribution width to albumin concentration ratio is associated with increased all-cause and cause-specific mortality.

Frontline treatment with acalabrutinib, bendamustine, and rituximab shows promising results in reducing disease progression and death in older mantle cell lymphoma patients.

Study reveals the significant impact of TP53 mutations on chronic lymphocytic leukaemia progression and survival, emphasising the importance of mutation type and treatment strategy

Results from a trial on the use of vitamin C supplementation for the treatment of low-risk myeloid malignancies were presented at the 2024 European Haematology Association Congress

Study found Mitapivat significantly raised haemoglobin levels and alleviated fatigue in patients with non–transfusion-dependent thalassemia.

Belantamab combination therapy shows significant improvements in survival for relapsed/refractory multiple myeloma patients compared to pomalidomide plus bortezomib and dexamethasone

Researchers have uncovered crucial insights into the development of paediatric acute myeloid leukaemia, revealing that some cases may originate in the womb

A new study finds that low-dose direct oral anticoagulants are linked to an increased risk of early bleeding episodes in patients with atrial fibrillation, compared to standard-dose